Polaris Venture Management Co. V »

Lyra Therapeutics shares owned by Polaris Venture Management Co. V

Quarter-by-quarter ownership of Lyra Therapeutics (LYRA) shares owned by Polaris Venture Management Co. V from 13F filings

Historical chart of Polaris Venture Management Co. V investment in Lyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lyra Therapeutics held by Polaris Venture Management Co. V consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyra Therapeutics by Polaris Venture Management Co. V

Quarter filed Position value Share count Share price at filing
2021-09-30 $10M 1.1M 9.12
2021-06-30 $8.8M 1.1M 8.03
2021-03-31 $13M 1.1M 11.59
2020-12-31 $13M 1.1M 11.40
2020-09-30 $12M 1.1M 11.18
2020-06-30 $13M 1.1M 11.34

More positions owned by Polaris Venture Management Co. V

Lyra Therapeutics Common Stock (LYRA)
x4 Pharmaceuticals Common Stock (XFOR)
Atyr Pharma Common Stock
Dare Bioscience Common Stock (DARE)
Genocea Biosciences Common Stock (GNCAQ)
Pulmatrix Common Stock

View all positions for Polaris Venture Management Co. V

Top funds holding Lyra Therapeutics

Perceptive Advisors
Nantahala Capital Management
Point72 Asset Management
Citadel Advisors
Samsara BioCapital
VR Adviser
Ikarian Capital
Rosalind Advisors
Vanguard Group
Millennium Management
Alyeska Investment Group
Bank of America Corporation
Two Sigma Investments
Citigroup
Clearline Capital

View all funds holding Lyra Therapeutics